The role of S100-positive dendritic cells in the prognosis of papillary thyroid carcinoma

American Journal of Clinical Pathology

Volumn 139, Issue 1, 2013, Pages 87-92

  Hilly, Ohad ^a   Koren, Rumelia ^a,b   Raz, Raanan ^b   Rath Wolfson, Lea ^a,b   Mizrachi, Aviram ^a,b   Hamzany, Yaniv ^a   Bachar, Gideon ^a,b   Shpitzer, Thomas ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Dendritic cells; Disease free survival; Papillary thyroid carcinoma; S100; Thyroiditis

Indexed keywords

PROTEIN S 100;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CELL DENSITY; DENDRITIC CELL; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC THYROIDITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID PAPILLARY CARCINOMA; THYROIDITIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CELL COUNT; COMORBIDITY; DENDRITIC CELLS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; S100 PROTEINS; SURVIVAL RATE; THYROID NEOPLASMS; THYROIDITIS, AUTOIMMUNE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84871747397     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPAKYDO56NKMYZ     Document Type: Article

References (24)

1. Banchereau J, Briere F, Caux C. Immunobiology of dendritic cells. Annu Rev Immunol. 2000;18:767-811. (Pubitemid 30365397)
2. Coventry B, Heinzel S. CD1a in human cancers: a new role for an old molecule. Trends Immunol. 2004;25:242-248. (Pubitemid 38501670)
3. Yamakawa M, Kato H, Takagi S, et al. Dendritic cells in various human thyroid diseases. In Vivo. 1993;7:249-256. (Pubitemid 23205702)
4. Yamakawa M, Yamada K, Orui H, et al. Immunohistochemical analysis of dendritic/Langerhans cells in thyroid carcinomas. Anal Cell Pathol. 1995;8:331-343.
5. McLaren KM, Cossar DW. The immunohistochemical localization of S100 in the diagnosis of papillary carcinoma of the thyroid. Hum Pathol. 1996;27:633-636. (Pubitemid 26240312)
6. Batistatou A, Zolota V, Scopa CD. S-100 protein+ dendritic cells and CD34+ dendritic interstitial cells in thyroid lesions. Endocr Pathol. 2002;13:111-115. (Pubitemid 34828131)
7. Tsuge K, Takeda H, Kawada S, et al. Characterization of dendritic cells in differentiated thyroid cancer. J Pathol. 2005;205:565-576. (Pubitemid 40514829)
8. Ugolini C, Basolo F, Proietti A, et al. Lymphocyte and immature dendritic cell infiltrates in differentiated, poorly differentiated, and undifferentiated thyroid carcinoma. Thyroid. 2007;17:389-393. (Pubitemid 46878841)
9. Xu W, Li X, Chen S, et al. Expression and distribution of S-100, CD83 and apoptosis-related proteins (Fas, FasL and Bcl-2) in tissues of thyroid carcinoma. Eur J Histochem. 2008;52:153-162.
10. Loh KC, Greenspan FS, Dong F, et al. Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J Clin Endocrinol Metab. 1999;84:458-463. (Pubitemid 29075669)
11. Kebebew E, Treseler PA, Ituarte PH, et al. Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited. World J Surg. 2001;25:632-637. (Pubitemid 32441438)
12. Matsubayashi S, Kawai K, Matsumoto Y, et al. The correlation between papillary thyroid carcinoma and lymphocytic infiltration in the thyroid gland. J Clin Endocrinol Metab. 1995;80:3421-3424. (Pubitemid 3019478)
13. Kashima K, Yokoyama S, Noguchi S, et al. Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma. Thyroid. 1998;8:197-202. (Pubitemid 28145182)
14. Singh B, Shaha AR, Trivedi H, et al. Coexistent Hashimoto's thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome. Surgery. 1999;126:1070-1077.
15. Schröder S, Schwarz W, Rehpenning W, et al. Dendritic/Langerhans cells and prognosis in patients with papillary thyroid carcinomas: immunocytochemical study of 106 thyroid neoplasms correlated to follow-up data. Am J Clin Pathol. 1988;89:295-300. (Pubitemid 18081228)
16. Edge S, Byrd D, Compton C, et al. American Joint Committee on Cancer Staging Manual. 7th ed. New York: Springer; 2010.
17. Sipos JA, Mazzaferri EL. Thyroid cancer epidemiology and prognostic variables. Clin Oncol (R Coll Radiol). 2010;22:395-404.
18. Schäffler A, Palitzsch KD, Seiffarth C, et al. Coexistent thyroiditis is associated with lower tumour stage in thyroid carcinoma. Eur J Clin Invest. 1998;28:838-844. (Pubitemid 28488118)
19. Del Rio P, Cataldo S, Sommaruga L, et al. The association between papillary carcinoma and chronic lymphocytic thyroiditis: does it modify the prognosis of cancer? Minerva Endocrinol. 2008;33:1-5.
20. Kim EY, Kim WG, Kim WB, et al. Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma. Clin Endocrinol (Oxf). 2009;71:581-586.
21. Mazokopakis EE, Tzortzinis AA, Dalieraki-Ott EI, et al. Coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma: a retrospective study. Hormones (Athens). 2010;9:312-317.
22. Lubina A, Cohen O, Barchana M, et al. Time trends of incidence rates of thyroid cancer in Israel: what might explain the sharp increase. Thyroid. 2006;16:1033-1040. (Pubitemid 46141306)
23. Howlader N. SEER Cancer Statistics Review, 1975-2008. Bethesda, MD: National Cancer Institute. Based on November 2010 SEER data submission, posted to the SEER website, 2011. Available at http://seer.cancer.gov/csr/1975-2008/. Accessed August 22, 2011.
24. Fiumara A, Belfiore A, Russo G, et al. In situ evidence of neoplastic cell phagocytosis by macrophages in papillary thyroid cancer. J Clin Endocrinol Metab. 1997;82:1615-1620. (Pubitemid 27200444)